FOLFIRINOX combination chemotherapy for patients with unresectable pancreatic cancer: A single-institution experience

FOLFIRINOX combination chemotherapy for patients with unresectable pancreatic cancer: A single-institution experience

Background and purpose: FOLFIRINOX combination chemotherapy (oxaliplatin, irinotecan, fluorouracil, and leucovorin) significantly improve prognosis of patients with metastatic pancreatic cancer.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-08, Vol.16 (4), p.S173-S173
Hauptverfasser: Takeda, Makoto, Sakaguchi, Takanori, Kiuchi, Ryouta, Morita, Yoshifumi, Konno, Hiroyuki
Format: Artikel
Sprache:eng
Schlagworte:
Chemotherapy
Endocrinology & Metabolism
Gastroenterology and Hepatology
Hematology
Medical prognosis
Metastasis
Neutropenia
Pancreatic cancer
Prescription drugs
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose: FOLFIRINOX combination chemotherapy (oxaliplatin, irinotecan, fluorouracil, and leucovorin) significantly improve prognosis of patients with metastatic pancreatic cancer.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2016.06.623